Sugi Predict

Sugi Predict / Compounds / SCHEMBL4485494

SCHEMBL4485494

SCHEMBL4485494

CC(=O)N(CCCN(C)C)c1ccc(NC(=C2C(=O)Nc3cc(Cl)ccc32)c2ccccc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ PLK1 P53350 3/20 0.36
▸ LCK P06239 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.35
▸ TMEM97 Q5BJF2 1/20 0.34
▸ SIGMAR1 Q99720 1/20 0.34
▸ TERT O14746 1/20 0.34
▸ UTS2R Q9UKP6 2/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ CFTR P13569 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ AHR P35869 1/20 0.33
▸ PDGFRB P09619 2/20 0.33
▸ KDR P35968 2/20 0.33
▸ PLK3 Q9H4B4 2/20 0.33
▸ KIT P10721 1/20 0.33
▸ FGFR1 P11362 1/20 0.33
▸ FLT3 P36888 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4485489 1.00 KDM4E (0.37) KDM4EALDH1A1PLK1LCKLRRK2
SCHEMBL225448 0.95 LRRK2 (0.36) KDM4EPLK1LCKLRRK2NPC1
SCHEMBL4491553 0.95 LIMK1 (0.37) KDM4EALDH1A1PLK1LRRK2TMEM97
SCHEMBL4491548 0.95 LIMK1 (0.37) KDM4EALDH1A1PLK1LRRK2TMEM97
SCHEMBL225449 0.95 LRRK2 (0.36) KDM4EPLK1LCKLRRK2NPC1
SCHEMBL4488448 0.92 LRRK2 (0.35) PLK1LCKLRRK2NPC1POLB
SCHEMBL4488452 0.92 LRRK2 (0.35) PLK1LCKLRRK2NPC1POLB
SCHEMBL4504212 0.92 ADRA2C (0.38) PLK1LRRK2TMEM97SIGMAR1RXFP1
SCHEMBL4504209 0.92 ADRA2C (0.38) PLK1LRRK2TMEM97SIGMAR1RXFP1
SCHEMBL4485666 0.91 KDM4E (0.35) KDM4EPLK1LRRK2NPC1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 — — US claimed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 — — US claimed
US-7514468-B2 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2009-04-07 — — US disclosed
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2006-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194813-A1 Indolinone derivatives substituted in the 6 position, the preparation thereof and their use as pharmaceutical compositions KDR, FLT1, EGFR KDM4E 1648/4885ALDH1A1 2036/4885PLK1 86/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.